Adel K El-Naggar Selected Research

ORALIT (ORS)

7/2015	Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.
3/2012	Family history of cancer and risk of sporadic differentiated thyroid carcinoma.
11/2008	Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adel K El-Naggar Research Topics

Disease

159	Neoplasms (Cancer) 11/2023 - 07/2002
45	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2002
30	Carcinoma (Carcinomatosis) 11/2023 - 10/2002
27	Carcinogenesis 01/2022 - 02/2002
20	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2002
19	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 02/2002
15	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 10/2004
12	Adenoid Cystic Carcinoma (Cylindroma) 11/2023 - 11/2006
12	Mouth Neoplasms (Oral Cancer) 03/2021 - 01/2008
11	Thyroid Neoplasms (Thyroid Cancer) 06/2020 - 12/2004
10	Anaplastic Thyroid Carcinoma 01/2019 - 12/2004
8	Adenocarcinoma 01/2022 - 12/2002
8	Papillary Thyroid Cancer 10/2017 - 02/2007
6	Mucoepidermoid Carcinoma 10/2017 - 07/2007
5	Disease Progression 01/2021 - 04/2008
5	Sarcoma (Soft Tissue Sarcoma) 04/2017 - 02/2007
4	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2021 - 07/2005
4	Lymphatic Metastasis 06/2020 - 01/2008
4	Laryngeal Neoplasms (Laryngeal Cancer) 01/2018 - 04/2009
4	Breast Neoplasms (Breast Cancer) 06/2012 - 12/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2011 - 12/2002
4	follicular Thyroid cancer 12/2010 - 06/2006
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 09/2005
3	Acinar Cell Carcinoma 08/2020 - 11/2010
3	Margins of Excision 01/2017 - 11/2007
3	Mucositis 01/2016 - 09/2010
3	Tongue Neoplasms (Tongue Neoplasm) 09/2012 - 07/2006
2	Xerostomia 01/2021 - 08/2008
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2017 - 06/2010
2	Extranodal Extension 01/2017 - 01/2016
2	Oropharyngeal Neoplasms 01/2016 - 10/2014

Drug/Important Bio-Agent (IBA)

40	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
24	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2004
22	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2003
17	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2004
9	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2004
9	Cetuximab (Erbitux)FDA Link 01/2023 - 07/2007
9	Phosphotransferases (Kinase)IBA 12/2022 - 11/2006
8	Keratins (Keratin)IBA 01/2023 - 07/2003
7	Transcription Factors (Transcription Factor)IBA 02/2023 - 10/2002
7	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016 - 04/2008
6	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 11/2006
6	LigandsIBA 01/2018 - 08/2006
6	RacivirIBA 08/2013 - 06/2006
5	Insulin-Like PeptidesIBA 01/2019 - 12/2002
5	RetinoidsIBA 01/2018 - 07/2005
5	MicroRNAs (MicroRNA)IBA 04/2017 - 10/2010
5	Cadherins (E-Cadherin)IBA 01/2011 - 06/2004
5	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2010 - 04/2006
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2010 - 06/2006
4	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 11/2008
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 11/2007
4	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 11/2007
4	Gefitinib (Iressa)FDA Link 01/2019 - 12/2004
4	ParaffinIBA 01/2018 - 08/2008
4	Glutamic Acid (Glutamate)FDA Link 06/2010 - 06/2005
4	Codon (Codons)IBA 06/2010 - 03/2005
4	Contrast MediaIBA 06/2009 - 03/2004
4	Messenger RNA (mRNA)IBA 05/2009 - 11/2004
4	Epidermal Growth Factor (EGF)IBA 07/2007 - 12/2004
4	AntibodiesIBA 01/2006 - 07/2003
3	Monoclonal AntibodiesIBA 01/2018 - 03/2004
3	ORALIT (ORS)IBA 07/2015 - 11/2008
3	Indicators and Reagents (Reagents)IBA 02/2015 - 11/2002
3	CytosineIBA 10/2010 - 10/2004
3	Mitogen-Activated Protein KinasesIBA 06/2010 - 01/2008
3	Hormones (Hormone)IBA 11/2007 - 06/2005
3	Estrogen Receptor betaIBA 11/2007 - 06/2005
3	Insulin-Like Growth Factor Binding Protein 3IBA 07/2006 - 12/2002
2	Immune Checkpoint ProteinsIBA 03/2021 - 01/2021
2	CarcinogensIBA 03/2021 - 01/2010
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2018
2	TransferasesIBA 01/2019 - 01/2006
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2018 - 08/2006
2	Retinoic Acid Receptor gammaIBA 01/2018 - 01/2006
2	Immune Checkpoint InhibitorsIBA 01/2018 - 12/2017
2	TensinsIBA 01/2018 - 06/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 06/2010
2	Cyclin D1IBA 10/2016 - 02/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2013 - 07/2007
2	Tumor Biomarkers (Tumor Markers)IBA 04/2013 - 09/2012
2	CytokinesIBA 06/2012 - 06/2010
2	cixutumumabIBA 12/2011 - 07/2007
2	Protein Isoforms (Isoforms)IBA 07/2011 - 07/2005
2	Somatomedin Receptors (Somatomedin Receptor)IBA 02/2011 - 07/2007
2	NF-kappa B (NF-kB)IBA 01/2011 - 08/2006
2	beta CateninIBA 01/2011 - 03/2005
2	Small Interfering RNA (siRNA)IBA 12/2010 - 05/2009
2	GuanineIBA 10/2010 - 06/2010

Therapy/Procedure

36	Therapeutics 01/2023 - 07/2002
34	Radiotherapy 11/2023 - 11/2002
14	Drug Therapy (Chemotherapy) 12/2022 - 07/2002
6	Neck Dissection (Radical Neck Dissection) 12/2021 - 08/2005
5	Chemoprevention 01/2018 - 04/2008
5	Induction Chemotherapy 01/2016 - 12/2003
4	Immunotherapy 12/2022 - 01/2018
4	Adjuvant Radiotherapy 12/2016 - 08/2004
2	Proton Therapy 01/2021 - 01/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2016 - 11/2010